SCHEMBL31123791

SCHEMBL31123791

O=C(Nc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 4/20 0.72
▸ METTL3 Q86U44 1/20 0.59
▸ METTL14 Q9HCE5 1/20 0.59
▸ SLC29A1 Q99808 3/20 0.59
▸ TP53 P04637 1/20 0.54
▸ ADORA3 P0DMS8 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ LMNA P02545 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ GLA P06280 1/20 0.53
▸ PMP22 Q01453 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ NPY1R P25929 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ NPY2R P49146 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24687181 1.00 ADK (0.72) ADKMETTL3METTL14SLC29A1TP53
SCHEMBL23023836 1.00 ADK (0.72) ADKMETTL3METTL14SLC29A1TP53
SCHEMBL25410585 0.92 ADK (0.60) ADKMETTL3METTL14SLC29A1
SCHEMBL31167393 0.92 ADK (0.60) ADKMETTL3METTL14SLC29A1
SCHEMBL29313461 0.91 ADK (0.60) ADKMETTL3METTL14SLC29A1ADORA3
SCHEMBL31228160 0.91 ADK (0.60) ADKMETTL3METTL14SLC29A1
SCHEMBL29313467 0.86 ADK (0.53) ADKMETTL3METTL14SLC29A1ADORA3
SCHEMBL22434979 0.85 ADK (0.52) ADKMETTL3METTL14SLC29A1ADORA3
SCHEMBL22434980 0.85 ADK (0.52) ADKMETTL3METTL14SLC29A1ADORA3
SCHEMBL24686959 0.84 ADK (0.51) ADKSLC29A1TP53ADORA3TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP disclosed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO disclosed
CN-112805006-B PRMT5 inhibitors 默沙东有限责任公司 2024-09-24 — — CN disclosed
Send feedback